PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 12098904

[Dnitrophenol--a dangerous doping agent].

Paal Sand·Steinar Madsen
View original source ↗Export metadata ↓

Abstract

BACKGROUND: Performance-enhancing drugs are frequently used by bodybuilders: anabolic steroids, growth hormone and insulin, only to mention a few. Many little known drugs are also used. MATERIAL AND METHODS: Two men aged 20 and 32 years, both active bodybuilders, complained about lassitude and malaise. Clinical and laboratory evaluation revealed an unusual cause of their complaints. RESULTS: Laboratory investigation showed very low serum levels of free thyroxin and thyroid stimulating hormone (TSH), suggesting central depression of thyroid function. Both men then admitted taking dinitrophenol (approximately 5 mg/kg bodyweight/day) to "burn fat" before body-building competitions. INTERPRETATION: Doctors should be aware that bodybuilders might use dinitrophenol. This toxic compound has severe metabolic effects. Overdose may cause hyperpyrexia and death. Use should be strongly discouraged.

Explore related subjects

2,4-DinitrophenolAdultAppetite DepressantsDoping in SportsHumansHypothyroidismMaleRisk FactorsWeight LiftingCase ReportsEnglish AbstractJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Paal Sand, Steinar Madsen. 2002-05-30. [Dnitrophenol--a dangerous doping agent].. https://pubmed.ncbi.nlm.nih.gov/12098904/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Ketone bodies alter dinitrophenol-induced glucose uptake through AMPK inhibition and oxidative stress generation in adult cardiomyocytes.

In aerobic conditions, the heart preferentially oxidizes fatty acids. However, during metabolic stress, glucose becomes the major energy source, and enhanced glucose uptake has a protective effect on heart function and cardiomyocyte survival. Thus abnormal regulation of glucose uptake may contribute to the development of cardiac disease in diabetics. Ketone bodies are often elevated in poorly controlled diabetics and are associated with increased cellular oxidative stress. Thus we sought to determine the effect of the ketone body beta-hydroxybutyrate (OHB) on cardiac glucose uptake during metabolic stress. We used 2,4-dinitrophenol (DNP), an uncoupler of the mitochondrial oxidative chain, to mimic hypoxia in cardiomyocytes. Our data demonstrated that chronic exposure to OHB provoked a concentration-dependent decrease of DNP action, resulting in 56% inhibition of DNP-mediated glucose uptake at 5 mM OHB. This was paralleled by a diminution of DNP-mediated AMP-activated protein kinase (AMPK) and p38 MAPK phosphorylation. Chronic exposure to OHB also increased reactive oxygen species (ROS) production by 1.9-fold compared with control cells. To further understand the role of ROS in OHB action, cardiomyocytes were incubated with H(2)O(2). Our results demonstrated that this treatment diminished DNP-induced glucose uptake without altering activation of the AMPK/p38 MAPK signaling pathway. Incubation with the antioxidant N-acetylcysteine partially restored DNP-mediated glucose but not AMPK/p38 MAPK activation. In conclusion, these results suggest that ketone bodies, through inhibition of the AMPK/p38 MAPK signaling pathway and ROS overproduction, regulate DNP action and thus cardiac glucose uptake. Altered glucose uptake in hyperketonemic states during metabolic stress may contribute to diabetic cardiomyopathy.

2,4-Dinitrophenol↗
PubMed2006

Effect of 2,4-dinitrophenol under non-oxygenated condition in pons-medulla-spinal cord preparations in newborn rats: comparison with medulla-spinal cord preparations.

We tested whether depression of respiratory frequency (fR) under non-oxygenated artificial cerebrospinal fluid (aCSF) in pons-medulla-spinal cord (PMS) and medulla-spinal cord (MS) preparations is significantly influenced by the mitochondrial uncoupler 2,4-dinitrophenol (2,4-DNP) in newborn rats. Preparations were obtained from 0- to 4-day-old rats, and fR was monitored at the C4 ventral root in environmental temperature (24 degrees C). 2,4-DNP was dissolved in aCSF (1, 10 or 30 microM; pH 7.4), and we measured fR in PMS (n=19) and MS (n=16), both of which were superfused with aCSF equilibrated with oxygenated (95% O2-5% CO2) or non-oxygenated (10% O2-5% CO2, balanced with pure N2) gas. Our results showed that: (1) fR was significantly lower in PMS than MS, (2) fR was significantly decreased under non-oxygenated aCSF in both PMS and MS and (3) fR under non-oxygenated aCSF was significantly increased by 2,4-DNP applications at 10 and 30 microM in PMS but not in MS. Our results suggest that depression in fR under non-oxygenated aCSF in PMS and MS may not be due simply to O2 limitation, and 2,4-DNP has a stimulant effect on the medullary respiratory rhythm generator (RRG) through pontine RRG regulatory mechanisms under non-oxygenated aCSF.

2,4-Dinitrophenol↗
PubMed2006

Comblike dendrimers containing Tn antigen modulate natural killing and induce the production of Tn specific antibodies.

Comblike glycodendrimers were prepared by the chemoselective ligation of cysteine-modified glycopeptides (1-7) with a 3-maleimidopropionate-modified linear synthetic carrier (8). Glycodendrimers bearing mono-, di-, or tri-Tn clusters (9-11) were tested as inhibitors using plant and mammalian lectins. In the former group, the Codium fragile lectin showed moderate discrimination among 9, 10, and 11. In the latter group, A and B isoforms of rat NKR-P1 lectin strongly discriminated between 9 and 10. 10 caused a 4-fold increase in killing of the NK resistant tumor cell lines at concentrations as low as 10(-8) M. Surprisingly, 11 interacted exclusively with the rat NKR-P1B isoform and inhibited efficiently natural killing in both rats and humans, even in the presence of the activating compounds 9 and 10. Dinitrophenol haptenization or influenza virus hemagglutinin T-cell epitope conjugation increased the immunogenicity of the parent compounds and resulted in the production of Tn specific antibodies.

2,4-Dinitrophenol↗